| 发明名称 |
SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS |
| 摘要 |
The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor. |
| 申请公布号 |
WO2012163990(A1) |
申请公布日期 |
2012.12.06 |
| 申请号 |
WO2012EP60194 |
申请日期 |
2012.05.31 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;WIENRICH, MARION;MAYOUX, ERIC |
发明人 |
WIENRICH, MARION;MAYOUX, ERIC |
| 分类号 |
A61K31/7034;A61K31/4515;A61K31/551;A61P3/04;A61P3/06;A61P3/08 |
主分类号 |
A61K31/7034 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
